Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187668 · ClinicalTrials.gov registry record
Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)
A clinical trial of Focus Groups, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT00187668: Completed study of Focus Groups, sponsored by University of California, San Francisco.
NCT00187668 is a study of Focus Groups that has completed, run by University of California, San Francisco. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187668, a study of Focus Groups, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Collect DNA from well-characterized healthy volunteers.
Primary Outcome
Amass a cohort of healthy controls to be used for future genotype to phenotype studies.
Conditions Studied
Study Locations (1)
California
- San Francisco General Hopsital CTSI CRC - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2004-02 |
| Est. Completion | 2023-08 |
What the finished NCT00187668 record still lists
NCT00187668 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Focus Groups appearing as the primary indexed condition, and to 0 interventions.
NCT00187668 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00187668 about?
NCT00187668 is a clinical study titled "Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)". Collect DNA from well-characterized healthy volunteers.
What is the current status of trial NCT00187668?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2004-02. Estimated completion is 2023-08.
What conditions does trial NCT00187668 study?
This clinical trial studies the following conditions: Focus Groups.
Who is sponsoring clinical trial NCT00187668?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00187668 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia